BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8297539)

  • 1. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
    Williams RR; Hunt SC; Hopkins PN; Wu LL; Hasstedt SJ; Berry TD; Barlow GK; Stults BM; Schumacher MC; Ludwig EH
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):319S-327S. PubMed ID: 8297539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins.
    Hunt SC; Hasstedt SJ; Kuida H; Stults BM; Hopkins PN; Williams RR
    Am J Epidemiol; 1989 Mar; 129(3):625-38. PubMed ID: 2916556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
    Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
    Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
    Haffner SM; Kushwaha RS; Hazzard WR
    Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.
    Williams RR; Hunt SC; Hopkins PN; Stults BM; Wu LL; Hasstedt SJ; Barlow GK; Stephenson SH; Lalouel JM; Kuida H
    JAMA; 1988 Jun; 259(24):3579-86. PubMed ID: 3373705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.
    de Bruin TW; Mailly F; van Barlingen HH; Fisher R; Castro Cabezas M; Talmud P; Dallinga-Thie GM; Humphries SE
    Eur J Clin Invest; 1996 Aug; 26(8):631-9. PubMed ID: 8872057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
    Williams RR; Hunt SC; Wu LL; Hopkins PN; Hasstedt SJ; Schumacher MC; Stults BM; Kuida H
    Klin Wochenschr; 1990; 68 Suppl 20():53-9. PubMed ID: 2189041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes.
    Emi M; Hegele RM; Hopkins PN; Wu LL; Plaetke R; Williams RR; Lalouel JM
    Arterioscler Thromb; 1991; 11(5):1349-55. PubMed ID: 1655017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
    McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
    Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.